Implants News and Research

RSS

Objet 3D Printer helps develop digital workflow for fabrication of dental implant models

Objet Ltd., the innovation leader in 3D printing for rapid prototyping and additive manufacturing today announced that Oratio B.V., a leading dental industry company in the Netherlands, has developed a complete in-house digital workflow for fabrication of models for dental implants with the help of an Objet 3D Printer.

6 Feb 2012

Wyatt Technology Instruments employed to develop alternative materials to silicone breast implants

Wyatt Technology Corporation today announced that Professor Judit E. Puskas at the University of Akron has developed a system using its instrumentation that will also help to solve a prevalent and particularly controversial material science challenge. The researchers are employing the multi detector system to develop alternative materials to silicone breast implants. This development will be welcomed by many as faulty Poly Implant Prothèse (PIP) implants are causing global concern about implant safety, and as a result, alternative materials are sought.

1 Feb 2012

BU scientists create unique material and drug delivery mechanism

Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. Now a team of researchers led by Boston University Biomedical Engineer and Chemist Mark Grinstaff has developed a unique material and drug delivery mechanism that could pave the way for implants that release a drug at a designated rate for months.

1 Feb 2012

CartiHeal secures $5M in venture funding

CartiHeal (2009), Ltd, a privately held medical device company, focused on developing and bringing to market a proprietary, off-the-shelf, and cell-free cartilage regeneration technology, announced that it raised $5 million in venture funding from two US-Israeli venture capital firms, Accelmed and Access Medical Ventures. The financing will be used to prepare its first product launch early 2013 in Europe.

1 Feb 2012

Custom Spine achieves ISO-13485 and receives CE Mark for all current products

In an effort to support global expansion plans, Custom Spine announced that it has achieved ISO-13485 and received CE Mark for all its current products sold in the U.S. This approval allows the Company to commercialize its products into the international market.

31 Jan 2012

Fat grafting may reduce radiation-induced complications in breast implants

For breast cancer patients who have undergone radiation therapy, a new technique consisting of fat injection followed by implant placement may provide a much-needed alternative for breast reconstruction, reports a study in the February issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

30 Jan 2012

ConforMIS raises $89M in Series E round of funding

Surpassing all previous fundraising rounds, privately-held medical device company ConforMIS, Inc. announced today that it has raised $89 million in a Series E round of funding, with additional funds beyond this amount committed upon meeting certain milestones.

30 Jan 2012

TiBREEZE breast implants included in explantation

The International Society for Aesthetic Plastic Surgery (ISAPS) has been officially informed by the German authorities at the BfArM Institute that the former company, GfE Medizintechnik GmbH in Germany, sold implants that were manufactured using PIP components.

30 Jan 2012

PIP breast implant mastermind arrested

The founder of the company - Poly Implant Prothese or PIP was arrested Thursday in an early-morning police raid on his luxury home in the south of France. The PIP implants have been the center of controversy and fear after reports of rupture of the breast implants due to use of second grade materials in their manufacture.

29 Jan 2012

Artificial testes being developed to help infertile men produce sperm

Californian researchers are trying to create an artificial testicle that will produce human sperm. Dr. Paul Turek, director of the Turek Clinic in San Francisco, which specializes in male infertility, said the goal is not to create a testicular implant for men, but a “sperm-making biological machine” that will help scientists learn more about just what causes male infertility. “We’re trying to recreate the process of sperm production in a three-dimensional system,” Turek said. “Simple laboratory conditions can’t get it done in humans. Our concept is to actually recreate the testicle itself.”

22 Jan 2012

Biotectix announces FIH use of electrostimulation device with BT DOT polymer coatings

Biotectix, LLC, an Allied Minds, Inc. subsidiary, is pleased to announce the first-in-human (FIH) use of an electrostimulation device incorporating its BT DOT conductive polymer coating technology.

19 Jan 2012

AxoGen reports results from Avance Nerve Graft clinical study on PNI

AxoGen, Inc., an emerging regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today reported the publication of peer-reviewed clinical research conducted at twelve leading US surgical sites and led by the Buncke Clinic in San Francisco.

16 Jan 2012

Man gets new windpipe with stem cell therapy

Christopher Lyles, 30, of Abingdon, Md, became the first American to undergo an experimental procedure, involving stem cells to treat his trachea cancer. A trachea or windpipe connects the nose and mouth to the lungs, serving a crucial function for life.

16 Jan 2012

Implanting more embryos for IVF may do more harm than good: Study

Researchers have suggested that implanting multiple embryos for In Vitro Fertilization (IVF) may do more harm than good. This finding appeared in the current online version of the journal Lancet. The study argues against common practice of implanting multiple embryos in order to maximize a woman’s chances of conception during in vitro fertilization.

15 Jan 2012

Health Secretary stands firm on the issue of removal of faulty breast implants

Britain’s Health Secretary Andrew Lansley intends to take cosmetic industry companies that are refusing free operations to women wanting substandard breast implants removed to court. Lansley is ready to take action after the declaration of the Harley Medical Group that it will not pay for removal of the PIP implants that have triggered great anxiety in women in the UK and in France. Transform and the Hospital Group have also said that women will have to pay.

12 Jan 2012

More on the PIP breast implant scare

Model Jasmine Lennard underwent an emergency operation to replace her breast implants after discovering they contained banned silicone. The 26-year-old admits that she became ‘hysterical’ after discovering her implants came from French firm PIP, which is at the centre of a global health scare for using industrial-grade materials deemed unfit for medical use. And she believes last week’s procedure could have ‘saved my life’.

9 Jan 2012

HCA issues commitment to offer full support to PIP breast implant patients

Last Friday the MHRA advised that they found no evidence to support routine removal of PIP breast implants and they recommended that any patients who were concerned about their implant should seek clinical advice from their consultant surgeon.

8 Jan 2012

AB receives TÜV approval for Neptune waterproof sound processor in Europe

Advanced Bionics (AB), the global leader in cochlear implant technology, announced today that it received approval in Europe for Neptune, the world's first and only swimmable, waterproof sound processor.

7 Jan 2012

Mazor Robotics receives European patent titled, 'Miniature Bone-mounted Surgical Robot'

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today announced that the European Patent Office granted European Patent No. 1414362 entitled "Miniature Bone-mounted Surgical Robot," which covers the Company's flagship product, Renaissance.

7 Jan 2012

FDA approves TGM's hip and knee systems and related surgical instruments

China Kanghui Holdings, a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that the Company's wholly-owned subsidiary, TGM Medical, Inc., has received approvals from the Food and Drug Administration of the United States for its Helicon Hip System ("HHS"), Milestone Knee System ("MKS") and related surgical instruments.

6 Jan 2012